Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Interstitial lung disease is not a single disease, but is instead a group of rare lung diseases that range from mild to severe and have different treatments and different outcomes. These diseases make it difficult for the lungs to exchange oxygen and carbon dioxide and can cause fluid and other materials to collect in the lungs. (See our Symptoms & Causes for a list of different ILDs).
How Boston Children’s Hospital approaches interstitial lung disease
Our Interstitial Lung Disease Program is made up of doctors, nurses, nutritionists and social workers who provide a full diagnosis and evaluation of each child with ILD.
We work with families to plan individualized therapy depending on the specific condition—to offer the best care of the child’s respiratory health, growth and nutrition. We help families arrange home health care support and supplies, transportation services and visiting nursing services. If needed, our Division of Pulmonary and Respiratory Diseases provides expert review and opinion, as well as other services and support, for lung transplantation.
Our ILD program is a part of the Children's Interstitial Lung Disease Research Network (ChILDRN), associated with the Children's Interstitial Lung Disease (ChILD) Foundation.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”